Ticagrelor Related Compound 8
|
|
Sicherheit
Ticagrelor Related Compound 8 Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
(1R,2R)-2-(3,4-Difluorophenyl)-cyclopropanecarbonyl Azide is a useful synthetic intermediate in the synthesis of Ticagrelor (T437700); the first reversible oral P2Y12 receptor antagonist that provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Ticagrelor is also used in the treatment of acute coronary syndromes (ACS).Ticagrelor Related Compound 8 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Ticagrelor Related Compound 8 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 17)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
China National Standard Pharmaceutical Corporation Limited | +8615391658522 |
overseasales@yongstandards.com | China | 11922 | 58 |
Hubei Yangxin Medical Technology Co., Ltd. | 15374522761 |
3003392093@qq.com | China | 8706 | 55 |
Shenzhen Chengbaina Pharmaceutical Technology Co., Ltd. | 13428940289 |
2126629366@qq.com | CHINA | 97 | 58 |
BOC Sciences | -- |
info@bocsci.com | USA | 0 | 65 |
Nanjing wangzhixing Pharmaceutical Technology Co., Ltd | 15850510341 |
shiqingran@wzxchem.com | China | 3788 | 58 |
Wuxi Minglu Medicine technology Co.,Ltd. | 0510-88726693 |
3204601684@qq.com | China | 2215 | 58 |
Meng Cheng Technology (Shanghai) Co., LTD | 400-820-6829 |
sales@mitachieve.com | China | 8860 | 58 |
Energy Chemical | 021-58432009 400-005-6266 |
marketing@energy-chemical.com | China | 44918 | 58 |
Suzhou Meishi Biotechnology Co., Ltd. | 1173954148q |
meishipharma@126.com | China | 20033 | 58 |
HX Pharmaceutical technology co., LTD | 15671363360 |
494267389@qq.com | China | 3630 | 58 |
- (1R,2R)-2-(3,4-difluorophenyl)cyclopropanecarbonyl azide
- Ticagrelor Impurity 277
- Ticagrelor Related Compound 8
- 378236-67-0